A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Carolina Rudah / iStock What is the Maximum Recommended Semaglutide Dose for Weight Loss? The maximum recommended semaglutide dose for weight loss is 2.4 milligrams (mg) per week. Your healthcare ...

AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

That is perhaps why there has been so much buzz surrounding the class of drug known as a GLP-1 agonist.

HealthDay News — Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers, including with respect to U.S. Food and Drug ...

For example, timings and storage conditions vary based on which type of semaglutide drug you’re taking. Yes, compounded semaglutide needs to be refrigerated. If compounded semaglutide is not ...

Rapid correction of hyperglycemia, rather than drug toxicity, may be associated with the observed ophthalmic complications. Further research is necessary to understand the potential ocular risks of ...

Drug compounders making copycat versions of Eli Lilly & Co. ’s tirzepatide are urging a federal judge to shield them from FDA enforcement while a court decides whether the agency lawfully stopped ...

What's All the Fuzz With GLP-1, Tirzepatide ... and physicians are allowed to compound these medications if they comply with Section 503A of the Federal Food, Drug, and Cosmetic Act or Section ...

Primary objective: Demonstrate that co-administration of bremelanotide with tirzepatide is safe and ... Investigational new drug (IND) enabling activities expected to commence 1Q calendar year ...